Swedbank AB Has $25.23 Million Holdings in Humana Inc. $HUM

Key Points

• Swedbank AB reduced its holdings in Humana Inc. by 15.4%, now owning approximately 0.08% of the company with a value of $25.23 million after selling 17,425 shares.
• Humana's quarterly earnings report showed an earnings per share (EPS) of $6.27, missing expectations, while revenue increased year-over-year by 9.6% to $32.39 billion.
• The company recently announced a quarterly dividend of $0.885, with a payout ratio of 27.17% and a current annualized dividend yield of 1.3%.

Swedbank AB reduced its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 15.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 95,365 shares of the insurance provider's stock after selling 17,425 shares during the quarter. Swedbank AB owned 0.08% of Humana worth $25,234,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in shares of Humana by 8.9% in the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock valued at $3,697,222,000 after acquiring an additional 1,143,662 shares during the period. Dodge & Cox increased its position in shares of Humana by 5.5% during the first quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider's stock worth $2,845,830,000 after purchasing an additional 557,175 shares in the last quarter. Pzena Investment Management LLC increased its position in shares of Humana by 6.1% during the first quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider's stock worth $1,013,133,000 after purchasing an additional 219,541 shares in the last quarter. Davis Selected Advisers grew its holdings in shares of Humana by 3.3% during the first quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider's stock valued at $616,873,000 after buying an additional 74,434 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC grew its holdings in shares of Humana by 1.6% during the first quarter. Hotchkis & Wiley Capital Management LLC now owns 1,236,936 shares of the insurance provider's stock valued at $327,293,000 after buying an additional 19,613 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Humana Stock Performance

Humana stock traded down $1.70 during midday trading on Monday, reaching $274.75. 1,271,657 shares of the stock traded hands, compared to its average volume of 1,618,744. The firm has a fifty day moving average price of $266.10 and a two-hundred day moving average price of $257.19. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The firm has a market cap of $33.04 billion, a price-to-earnings ratio of 21.09, a PEG ratio of 1.62 and a beta of 0.44. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $324.38.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.39 billion for the quarter, compared to analysts' expectations of $31.85 billion. During the same quarter in the prior year, the firm earned $6.96 earnings per share. The company's revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. On average, equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. Humana's dividend payout ratio (DPR) is 27.17%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on HUM shares. Sanford C. Bernstein increased their target price on shares of Humana from $269.00 to $341.00 and gave the stock an "outperform" rating in a research note on Friday, September 5th. Wall Street Zen cut shares of Humana from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Piper Sandler cut their target price on shares of Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a research note on Thursday, July 31st. Truist Financial reduced their price objective on Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Finally, Barclays boosted their target price on Humana from $275.00 to $315.00 and gave the company an "equal weight" rating in a report on Friday, September 5th. Seven equities research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $289.24.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.